RxDoctor Payments Data

Brett Gurden, PA

Physician Assistant · The Villages, FLNPI 1124544036

Payments from drug & device makers

$1,364in general payments, 2019–2025

Across 75 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$309
  • Amgen$238
  • Pfizer$228
  • AbbVie$109
  • Novartis$98
  • GSK$71
  • plus $313 from 11 others

What the payments were for

  • Food & beverage$1,364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,364 in reported general payments places this provider in the 65th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$16,830
Medicare patients
105
Services billed
248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$44,107
OzempicSemaglutide31$30,480
FarxigaDapagliflozin Propanediol20$24,903
JardianceEmpagliflozin14$22,091
JanuviaSitagliptin Phosphate19$20,535
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$19,855
XareltoRivaroxaban12$17,765
Spiriva RespimatTiotropium Bromide27$14,426
LinzessLinaclotide19$13,935
Repatha SureclickEvolocumab18$11,525
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$7,599
BelsomraSuvorexant12$5,244
Atorvastatin Calcium222$2,947
Albuterol Sulfate HfaAlbuterol Sulfate110$2,652
Potassium Chloride103$2,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$228$44,10751 claims
Boehringer IngelheimJardiance, Spiriva Respimat$16$36,51741 claims
Novo NordiskOzempic$309$30,48031 claims
GSKTrelegy Ellipta, Anoro Ellipta$71$27,45449 claims
AstraZenecaFarxiga$32$24,90320 claims
AbbVieLinzess$109$13,93519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in The Villages

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →